Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07125027 · ClinicalTrials.gov registry record · NA
A Multicomponent Intervention for Patients With Lumbosacral Radiculopathy: Move-MORE
A NA study of Sciatica and Lumbosacral Radiculopathy, sponsored by National University of Natural Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT07125027: Recruiting NA study of Sciatica and Lumbosacral Radiculopathy, sponsored by National University of Natural Medicine.
NCT07125027 is a NA study of Sciatica and Lumbosacral Radiculopathy that is actively recruiting participants, run by National University of Natural Medicine. The registered enrollment target is 32 participants, below the 82-participant average among 6 other Sciatica trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07125027, a NA study of Sciatica and Lumbosacral Radiculopathy, is actively recruiting participants, sponsored by National University of Natural Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The Move-MORE study is designed to evaluate a multicomponent mindfulness and movement program for patients with lumbosacral radiculopathy. The program brings together mindfulness training to help participants develop awareness of their body and manage pain-related stress, gentle movement practice to improve comfort with physical activity and support function, and motivational interviewing to strengthen motivation, confidence, and the ability to make healthy changes. The main objectives are to determine whether it is feasible for participants to use each component of the program when delivered online, to assess how acceptable and engaging each component is, and to evaluate the impact on pain, physical function, and daily activity levels. The study intervention will be conducted entirely remotely. Participants will complete online surveys, brief daily check-ins on their phone, and wear a small activity monitor on the hip to measure movement. They will also undergo quantitative sensory testing to evaluate pain sensitivity. At the end of the program, participants will share feedback about their experiences via qualitative interviews. The findings will help identify which parts of the program provide the greatest benefit, with the ultimate goal of developing a more targeted and effective digital program for people with this condition.
Primary Outcome
The proportion of patients contacted who consent to screening
Conditions Studied
Interventions
- BEHAVIORAL Move-MORE
Study Locations (1)
Oregon
- National University of Natural Medicine - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2025-08-15 |
| Est. Completion | 2026-11 |
| Phase | NA |
What NCT07125027 shows while recruiting
NCT07125027 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 82-participant average among 6 other Sciatica trials with a reported enrollment target (61% lower).
The record links to 5 conditions, with Sciatica appearing as the primary indexed condition, and to 1 intervention - of which Move-MORE is the first listed.
NCT07125027 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT07125027 about?
NCT07125027 is a clinical study titled "A Multicomponent Intervention for Patients With Lumbosacral Radiculopathy: Move-MORE". The Move-MORE study is designed to evaluate a multicomponent mindfulness and movement program for patients with lumbosacral radiculopathy. The program brings together mindfulness training to help participants develop awareness of their body and manage pain-related stress, gentle movement practice to...
What is the current status of trial NCT07125027?
This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2025-08-15. Estimated completion is 2026-11.
What conditions does trial NCT07125027 study?
This clinical trial studies the following conditions: Sciatica, Lumbosacral Radiculopathy, Chronic Pain (Back / Neck), Radiculopathy Lumbar, Chronic Low Back Pain With a Neuropathic Component.
What interventions are being tested in trial NCT07125027?
The interventions under investigation include: Move-MORE (BEHAVIORAL).
Who is sponsoring clinical trial NCT07125027?
This trial is sponsored by National University of Natural Medicine, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07125027 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sciatica
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Efficacy of Oral Steroids in the Treatment of Acute Sciatica
COMPLETED · Phase 3
-
Efficacy of Epidural Etanercept in the Treatment of Sciatica
COMPLETED · Phase 1
-
Magnets in the Treatment of Sciatica
COMPLETED · Phase 2
-
Pain Treatment for Sciatica
COMPLETED · Phase 2
-
Study to Evaluate the Safety and Efficacy of Placulumab (CEP-37247) Administered by the Transforaminal Epidural Route for the Treatment of Patients With Lumbosacral Radicular Pain Associated With Disk Herniation
COMPLETED · Phase 1
-
A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI